McDavid Stilwell | Vice President, Corporate Communications & Investor Relations |
Sandy Macrae | Chief Executive Officer |
Kathy Yi | Chief Financial Officer |
Stephane Boissel | Executive Vice President, Corporate Strategy |
Adrian Woolfson | Executive Vice President & Head of Research and Development |
Ed Conner | Chief Medical Officer |
Qian Wang | Bank of America Merrill Lynch |
Ritu Baral | Cowen and Company |
Jim Birchenough | Wells Fargo Securities |
Maury Raycroft | Jefferies |
Evan Wang | Guggenheim Securities |
Eric Joseph | JP Morgan |
Good afternoon and welcome to the Sangamo Therapeutics Teleconference to discuss Fourth Quarter and Full-year 2018 Financial Results. This call is being recorded. I will now pass you over to the coordinator of this event, McDavid Stilwell, Vice President of Corporate Communications and Investor Relations.
Hello and thank you for joining us.
As we begin, I'd like to point out that we'll be referencing an accompanying slide presentation, a link to the slide presentation may be found on our website, sangamo.com, on the events and presentations page of the Investors and Media section of the site.